Here’s why the ‘Cass Review’ matters—even if you aren’t in the U.K.
ANALYSIS: A new report is setting the stage for the future of trans healthcare in the U.K.—and it could spell bad news
ANALYSIS: A new report is setting the stage for the future of trans healthcare in the U.K.—and it could spell bad news